Qinglin Kang
Beijing, 100071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Humanized VHH-hFc Fusion Proteins Targeting the L-HN Fragment of Tetanus Toxin Provided Protection In Vivo.
Journal: Antibodies (Basel, Switzerland)
Published: April 14, 2025
Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies.
Journal: International journal of molecular sciences
Published: April 03, 2025
Fluorescence Reduction Neutralization Test: A Novel, Rapid, and Efficient Method for Characterizing the Neutralizing Activity of Antibodies Against Dengue Virus.
Journal: Current issues in molecular biology
Published: January 22, 2025
Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin.
Journal: Human vaccines & immunotherapeutics
Published: June 27, 2024
Neutralizing chimeric anti-F1 monoclonal antibody against Yersinia pestis infection.
Journal: International journal of antimicrobial agents
Published: June 11, 2024
A novel human anti-TIGIT monoclonal antibody with excellent function in eliciting NK cell-mediated antitumor immunity.
Journal: Biochemical and biophysical research communications
Published: November 16, 2020
Biogenic nanoparticles as immunomodulator for tumor treatment.
Journal: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Published: February 02, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026